At the beginning of 2025, almost 800 critically ill patients were waiting to start treatment (they should be seen within a week, according to gov standards)
Recent Developments: Initiated Phase 3 trials for maritide (caftaglutide), targeting both GLP-1 and GIP receptors
It's unknown if combining them could exacerbate certain side effects
After one day, puromycin selection was started until kill control was dead
Common GLP-1 medications include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro, Zepbound) These medications help with weight loss by: Reducing appetite and food cravings Making you feel full sooner during meals Slowing digestion so you stay satisfied longer Helping regulate blood sugar levels Most people receive these medications as weekly injections, though some come as daily pills
This extended presence helps maintain a feeling of fullness, decreasing the temptation to snack on unhealthy foods between meals